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Background: The incidence of severe acute respiratory tract infections in children caused by Mycoplasma
pneumoniae (syn. Schizoplasma pneumoniae) and Chlamydophila pneumoniae (formerly Chlamydia pneumoniae)
varies greatly from year to year and place to place around the world. This study investigated the epidemiology of
M. pneumoniae and C. pneumoniae infections among children hospitalized with acute respiratory infections in
Suzhou, China in the year 2006, and associations between incidence rates and climatic conditions.
Methods: Nasopharyngeal aspirates obtained from 1598 patients (aged 26.4 ± 28.3 months; range, 1 month to 13
years) were analyzed with real-time PCR and ELISA. Meteorological data were obtained from the weather bureau.
Results: About 18.5% of patients were infected with M. pneumoniae and, C. pneumoniae, or both. Isolated M.
pneumoniae infection was positively correlated with increasing age (χ2 = 34.76, P < 0.0001). Incidence of M.
pneumoniae infection was seasonal with a peak in summer (P < 0.0001) and minimum in winter (P = 0.0001),
whereas C. pneumoniae infection was low only in autumn (P = 0.02). Monthly mean temperature was strongly
correlated with the incidence of M. pneumoniae infection (r = 0.825, P = 0.001).
Conclusions: M. pneumoniae and C. pneumoniae are important infectious agents in hospitalized children with acute
respiratory tract infections. M. pneumoniae infection showed a strong direct correlation with environmental
temperature.
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ChinaIntroduction
The atypical pathogens Mycoplasma pneumoniae (syn.
Schizoplasma pneumoniae), Chlamydophila pneumoniae
(Chlamydia pneumoniae), and Legionella pneumophila
cause mild, moderate, or severe acute respiratory tract
infections (ARTIs) in children, although Legionella
pneumophila infection is more common in adults. These
infections occur worldwide [1-3]. Cyclical outbreaks of* Correspondence: szdxjiwei@163.com
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reproduction in any medium, provided the orM. pneumoniae infections can be expected on average
every 3–7 years, but at any given time may account for
as many as 40% of community-acquired pneumonia
cases [3]. The prevalence of C. pneumoniae in children
with ARTIs varies from 0 to 44% [4].
Studies of possible associations between the epidemiology
of atypical pathogens and meteorological conditions
(e.g., temperature, humidity, rainfall, amount of solar
radiation and wind velocity) are few. However, it was
recently reported that the community incidence of
pneumonia due to M. pneumoniae increased weekly
by 16.9% for every 1°C increase in the average temperature,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Community-acquired M. pneumoniae or C. pneumoniae
infections affect mainly preschool- and school-aged
children and young adults. Few studies have reported
the frequency of M. pneumoniae and C. pneumoniae
infections in infants [6].
Clinically it is difficult to distinguish M. pneumoniae
from C. pneumoniae infections and hence laboratory tests
are essential in identifying these pathogens. Serological
detections, although commonly used, are complicated by
false negative results in the early acute phase of infection,
and the difficulty in obtaining convalescent serum
during hospital stays of one week or less. Polymerase
chain reaction (PCR) is suitable for rapid diagnosis
of these infections, even when the colonization rate
is only 1-2% of the population [7-9]. Combining
both PCR and serology seems to be a more reliable
diagnostic approach.
The incidence rate of childhood ARTIs due to these
pathogens is very different from one country to another
[2-6]. Our purpose was to use PCR to identify and deter-
mine the percentage of ARTIs that were due to M.
pneumoniae and C. pneumoniae, especially in infants, and
investigate the relatedness between their epidemiology and
meteorological conditions in Suzhou, Jiangsu Province,
China. In addition we compared the clinical characteristics
of M. pneumoniae and C. pneumoniae infections, host




From 1 January 2006 to 31 December 2006, 1598
consecutive children with ARTIs admitted to Children’s
Hospital affiliated with Soochow University were enrolled
and evaluated prospectively. These children were hospital-
ized because of prolonged fever (>3 d), severe symptoms
of cough, wheeze, tachypnea, and chest retractions. The
clinical outcome and diagnosis for all children were
obtained after discharge from the hospital. The discharge
diagnosis was based on standard clinical criteria made
by attending physicians. Upper respiratory tract infec-
tion was diagnosed if a child had nasal obstruction,
nasal discharge, fever, or sore throat. Lower respiratory
tract infection was diagnosed when wheeze, tachypnea,
chest retractions, abnormal auscultatory findings, and
radiologic evidence of a lower respiratory tract infec-
tion were present. Children were excluded from the
study if they had proven chronic lung disease, immuno-
deficiency, congenital heart disease, or bronchopulmonary
dysplasia. The Institutional Review Boards of Suzhou
University approved the study protocol, and the parents
or legal guardians of each child gave informed written
consent.Methods
Sample collection
Nasopharyngeal aspirate (NPA) samples were obtained
from each patient within 24 hours of admission using a
sterile plastic catheter introduced into the lower part of the
pharynx via the nasal cavity. The samples were immediately
transported to the Laboratory of Molecular Biology of
our hospital for detection of M. pneumoniae and C.
pneumoniae using PCR. Seven common respiratory
virus (respiratory syncytial virus, influenza A and B,
parainfluenza 1, 2, 3 and adenovirus ) using direct
immunofluorescence and human metapneumovirus
using RT-PCR described previously [10]. Blood samples
were also obtained at admission and immediately sent to
the Department of Biochemical Laboratory for routine
blood, C-reactive protein, humoral and cell immunity, and
alanine transaminase tests.
DNA extraction
Each NPA sample was diluted in 2 mL of normal saline
before centrifugation at 500 × g for 10 minutes. The result-
ant cell pellet was resuspended and then centrifuged at 12
000 × g for 5 minutes, followed by extraction of DNA from
a 400-μL sample using DNA-EZ Reagents (Sangon Biotech,
USA) in accordance with the manufacturer’s instructions.
A final 200 μL of DNA was eluted and divided into 2
aliquots for PCR and stored at −20°C.
Detection of M. pneumoniae gene by real-time PCR
Real-time PCR was performed to identify the P1 adhesion
protein gene of M. pneumoniae, as described previously
[11]. The forward and reverse primers were 5’-CCA ACC
AAA CAA CAA CGT TCA-3’ and 5’-ACC TTG ACT
GGA GGC CGT TA-3’, respectively, and the probe
sequence was 5’-TCA ACT CGA ATA ACG GTG ACT
TCT TAC CAC TG-3’. The fluorescent reporter dye at the
5’ end was 6-carboxyfluorescein (FAM) and the
quencher at the 3’ end was 6-carboxytetramethylrhodamine
(TAMRA). The PCR reactions consisted of a 21-μL PCR
mast mixture (Shenyou Biotechnology, Shanghai, China)
including primers and probes combined with 3 μL of the
sample DNA and 1 U GoTaq DNA Polymerase (Promgea,
Wisconsin, USA). Real-time PCR was performed using an
iCycler iQ5 real-time PCR detection system (Bio-Rad,
Hercules, CA, USA) and cycling conditions were: 2 min at
37°C; 10 min at 94°C, and 40 cycles of 10 s at 94°C, 30 s at
55°C, and 40 s at 72°C.
Quantification curves were plotted using several concen-
trations of control plasmids containing the target gene.
Detection of C. pneumoniae gene by nested-PCR
A different aliquot of extracted DNA from the NPA
sample was used for detecting the gene of the major
outer membrane protein of C. pneumoniae by nested
Table 1 Three-component score system for assessing tidal
lung function
Parameters Scores
0 1 2 3
PTEF/t-PTEF(mL/s2) <3 3-6 7-10 >10
25TEF/PTEF (%) >80 60-80 40-60 <40
t-PTEF/t-E (%) >30 20-30 10-20 <10
The score for 5 levels of tidal lung function. Normal: 0, Mild: <3, moderate:
3–5, Severe: 6–7, Extremely severe: 8–9. PTEF peak tidal expiratory flow, t-PTEF
time to peak tidal expiratory flow, 25TEF tidal expiratory flow at 25% of tidal
volume remaining, t-E, expiratory time.
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and internal primers were: Cpex-F 5’-TTA CAA GCC
TTG CCT GTA GG-3’; Cpex-R 5’-GCG ATC CCA AAT
GTT TAA GGC-3’; Cpin-F 5’-TTA TTA ATT GAT GGT
ACA AT A-3’; and Cpin-R 5’ATC TAC GGC AGT AGT
ATA GTT-3’. Amplifications were performed in a thermal
cycler (GeneAmp PCR System 9600, Applied Biosystems).
For the first amplification, 0.4 μM of each CPex-F and
Cpex-R primer and 2 U GoTaq DNA polymerase
(Promgea, Madison, WI, USA) were included in these
touchdown PCR reactions. The annealing temperature was
lowered 1°C every 2 cycles, from 65°C until touching down
at 55°C, at which temperature 20 more cycles were
performed. The denaturation and extension temperature
were constant at 94°C and 72°C, respectively. One micro-
liter of the products of the first round of amplification by
external primers were added into the PCR reactions of the
second round amplification using internal primers. The
second PCR cycling conditions were: 2 min at 95°C; and 30
cycles of 1 min at 94°C, 1 min at 50°C, and 1 min at
72°C. The nested PCR products were separated via 1.5%
agarose gel electrophoresis and visualized using eth-
idium bromide staining.
Serology testing for M. pneumoniae and C. pneumoniae
The presence of specific IgM and IgG antibodies againstM.
pneumoniae were investigated in serum samples of patients
using a commercial ELISA kit (Serion ELISA classic M.
pneumoniae IgG/IgM, Institute Virion\Serion, Germany).
IgA and IgG antibodies against C. pneumoniae were
detected with Serion ELISA classic C. pneumoniae IgA/IgG
Kits. Evidence of acute M. pneumoniae infection was
defined as either a single positive serum IgM (cutoff
13 U/mL) or a 4-fold increase in IgG in convalescent serum
obtained a week after admission. Acute C. pneumoniae
infection was defined as either a single positive serum
IgA (cutoff 3 U/mL) or a 4-fold increase in IgG in
convalescent serum.
Diagnostic criteria for M. pneumoniae and C. pneumoniae
acute infection
Acute infection due to M. pneumoniae or C. pneumoniae
was confirmed when any of the following was determined:
NPA samples proved positive via PCR, serum samples
positive for IgM or IgA, respectively, or IgG increasing
4-fold from the acute to the convalescent phases.
Tidal breathing measurements
Measurements of tidal breathing in most infants were
performed during natural and quiet sleep as assessed by
behavioral criteria [13]. Tidal breathing flow-volume
loops were obtained and analyzed with a commercially
available pediatric pulmonary function device (ECOMedics,
V’max 26, Switzerland). Tidal breathing measurementsincluded flow and volume signals, and were assessed by
professional staff. Lung function was graded as normal,
mild, moderate, severe, or extremely severe according
to three-component score system which could reflect
underlying obstructive airways disease [14,15] as
shown in Table 1.
Meteorological data
The primary investigator obtained data regarding
monthly mean temperatures, relative humidity, rainfall,
solar radiation, and mean wind velocity from the local
weather bureau for lat 31.19° N, long 120.37° E. Suzhou
has a subtropical climate and the monthly data for
meteorological variables were shown in Figure 1.
Statistical analyses
Categorical data were analyzed using the Cochran-
Mantel-Haenszel statistic or the chi-squared (χ2) or Fisher’s
exact tests. The continuous variables were compared using
analysis of variance (ANOVA). The Kruskal-Wallace test
was used if the data were abnormal in distribution or
nonparametric. The associations between meteorological
conditions and the prevalence of the 2 pathogens
were evaluated using Spearman’s rank correlations. A
P-value < 0.05 was considered statistically significant.
All analyses were performed using the Statistical Package
for SAS for windows, version 8.2 (SAS, USA).
Results
Epidemiology
Of the 1598 children admitted to our hospital for
ARTIs, 957 (59.9%) were boys, and the ratio of boys
to girls was 1.5:1. The mean age was 26.4 ± 28.3
months (range: 1 month to 13 years). Of all the children,
817 (51.1%) were aged < one year, 616 (38.5%) were 1–5
years, and 165 (10.3%) were >5 years old.
Twenty-three cases of M. pneumoniae infection and 6
cases of C. pneumoniae infection had co-infections with
other viruses (data not shown), and cases ofM. pneumoniae
or C. pneumoniae coinfection with viruses were excluded in
this study. ARTIs were caused by M. pneumoniae or C.
pneumoniae in 295 (18.5%) of the patients. The mean age
Figure 1 The monthly data for meteorological variables in Suzhou, China.
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boys, and the ratio of boys to girls was 1.4:1. Of the 295
infected with either or both of these pathogens, 199 (12.5%)
were due to M. pneumoniae alone (mean age 35.8 ± 37.3
months), 81 (5.1%) were due to C. pneumoniae alone (mean
age 27.3 ± 34.5 months), and 15 (5.1%) were co-infected
(mean age 28.0 ± 29.7 months). The infection rate due to
M. pneumoniae only was significantly and positively associ-
ated with increasing age (χ2 = 34.76, P < 0.0001). With
regard to demographic data, no significant difference in
gender or prematurity was found among the 3 etiological
groups (Table 2).
Seasonality and correlations with meteorological
conditions
Both M. pneumoniae and C. pneumoniae infections
occurred throughout the year. The M. pneumoniaeTable 2 The prevalence and demographic data of
children hospitalized with M. pneumoniae and C.
pneumoniae infection
M. pneumoniae a C. pneumoniae b Co-infection c
Age n/total (%) n/total (%) n/total (%)
<1 year 80/817 (9.8) 40/817 (4.9) 8/817 (0.1)
1 to 5 years 75/616 (12.2) 30/616 (4.9) 5/616 (0.1)
>5 years 44/165 (26.7) 11/165 (6.7) 2/165 (0.1)
Total 199/1598 (12.5) 81/1598 (5.1) 15/1598 (0.1)
Demographics n (%) n (%) n (%)
Total (male) 116 (58.3) 46 (56.8) 9 (60)
Prematurity 12 (6.0) 4 (4.9) 1 (6.7)
PICU
Admission
1 (0.5) 0 (0) 0 (0)
a χ2CMH = 35.90, P < 0.0001;
b χ2CMH = 0.98, P = 0.614;
c χ2CMH = 0.25, P = 0.881
compared among three age groups (Cochran-Mantel-Haenszel Statistic test).
Data are presented as number (percentage) or mean ± SD.infection rate reached a maximum in summer (P < 0.0001)
and a minimum in winter (P = 0.0001), whereas the C.
pneumoniae infection rate was lowest in autumn (P = 0.02;
Table 3). The peak number of M. pneumoniae infections
occurred in July (23.2% or 32/138) and were the lowest
(4.3% or 5/117) in December. C. pneumoniae infections
were also high in July (12.3% or 17/138; Figure 2).
Rates of M. pneumoniae infection in hospitalized chil-
dren in Suzhou correlated strongly with monthly mean
temperature, and weakly with monthly mean wind velocity
(Table 3). There was no significant correlation between
meteorological conditions and C. pneumoniae infections.
Clinical manifestations
There was no significant difference in terms of clinical
manifestations among the groups except for feverTable 3 The seasonality and correlations with climatic
conditions of M. pneumoniae and C. pneumoniae
infection in hospitalized children
M. pneumoniae C. pneumoniae
Seasons n (%) n (%)
Spring (Mar-May) 43 (11.0) 26 (6.6)
Summer (Jun-Aug) 86 (20.4) a 32 (7.6)
Autumn (Sep-Nov) 57 (13.9) 15 (3.6) c
Winter (Dec-Feb) 28 (7.5) b 23 (6.1)
Meteorological conditions r P r P
Temperature (°C) 0.825 0.001 −0.021 0.948
Relative humidity (%) 0.527 0.782 0 1.0
Rainfall (mm) 0.189 0.557 0.294 0.354
Sum of sunshine (h) 0.392 0.208 0.070 0.829
Wind velocity (m/s) 0.629 0.028 0.443 0.149
a P < 0.0001; b P = 0.0001; c P = 0.02 (prevalence of infections in a particular
season compared to the mean prevalence in all other seasons).
r Spearman coefficient.
Figure 2 The seasonality of M. pneumoniae and C. pneumoniae infections in hospitalized children. MP, M. pneumoniae; CP,
C. pneumoniae.
Table 4 Clinical manifestations of children hospitalized
with M. pneumoniae and C. pneumoniae infection
M. pneumoniae C. pneumoniae Co-infection
Hospitalization (d) 7.5 ± 2.3 7.3 ± 1.9 8.1 ± 2.3
Clinical manifestations, n (%)
Cough 189 (95.0) 75 (92.6) 14 (93.3)
Wheezing 57 (28.6) 31 (38.3) 6 (40)
Nose running 40 (20.1) 21 (25.9) 5 (33.3)
Fever 114 (57.3) a 36 (44.4) 12 (80) b
Dyspnea 12 (6.0) 4 (4.9) 1 (6.7)
Anorexia 22 (11.1) 7 (8.6) 3 (20)
Gastrointestinal 30 (15.1) 17 (21.0) 4 (26.7)
Tachypnea 31 (15.6) 12 (14.8) 3 (20)
Cyanosis 2 (1.0) 0 (0) 0 (0)
Other diagnoses, n (%)
URTI 10 (5.0) 8 (9.9) 1 (6.7)
LRTI 171 (85.9) 66 (81.5) 13 (86.7)
Asthma
exacerbation
18 (9.0) 7 (8.6) 1 (6.7)
a M. pneumoniae group compared with C. pneumoniae group, P = 0.05.
b Co-infection group compared with C. pneumoniae group, P = 0.011.
URTI, upper respiratory tract infection; LRTI, lower respiratory tract infection.
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with M. pneumoniae and C. pneumoniae were found
to have fever more frequently. There were no significant
differences in length of hospital stay among the different
groups. All patients were cured or improved.
Laboratory findings
There were no significant differences in laboratory
findings (routine blood, C-reactive protein level,
humoral and cell immunity, alanine transaminase,
radiographic data, and tidal lung function test) among
the 3 groups (Table 5).
Discussion
M. pneumoniae and C. pneumoniae are two common
atypical pathogens that cause ARTIs in children world-
wide. Infections may be endemic or epidemic. In the
present study, the total rate of M. pneumoniae and C.
pneumoniae infections in hospitalized children with
ARTIs in Suzhou, China for the year 2006 was 18.4%
(295/1598), in which 12.5% and 5.1% were caused only
by M. pneumoniae or C. pneumoniae, respectively. In
other recent studies in which real-time PCR was used
for identification, Defilippi et al. [16] in Genoa, Italy
reported an infection rate for M. pneumoniae in children
of 11.8% and in Tokyo, Japan Hamano-Hasegawa et al.
[17] found a rate of 14.8%. The rates of M. pneumoniae
infection found via real-time PCR tests in Suzhou, China
in the years 2007 and 2008 were 5.39% and 6.36%,
respectively (unpublished results). Hosker et al. [18]
reported an epidemic of M. pneumoniae infection in
Hong Kong with a rate of 15% to 20% that occurred
from 1986 to 1988, which was similar to our study.Apparent seasonality of M. pneumoniae infection was
observed in this study, with a peak level in summer and
the highest rate in July. When the disease is endemic,
seasonality may not be a factor, but when it is an epidemic
more cases occur in the summer or early autumn [3,16].
We observed a similar trend in this study. Onozuka et al.
[5] found a strong correlation between temperature and
relative humidity and the number of M. pneumoniae
Table 5 No significant differences in laboratory findings of children hospitalized with M. pneumonia and
C. pneumoniae infection
M. pneumoniae C. pneumoniae Co-infection
(n = 199) (n = 81) (n = 15)
Cell immunity
CD3+ (%) 63.6 ± 9.4 65.3 ± 9.3 61.9 ± 8.3
CD3 + CD4+ (%) 36.8 ± 8.2 37.5 ± 8.6 33.9 ± 4.4
CD3 + CD8+ (%) 22.9 ± 6.7 24.1 ± 5.7 23.6 ± 8.1
CD4/CD8 (%) 1.8 ± 0.8 1.7 ± 0.7 1.6 ± 0.6
CD3-CD19+ (%) 26.2 ± 9.8 26.1 ± 8.9 29.7 ± 9.2
CD3-CD (16 + 56+) (%) 8.8 ± 5.7 6.6 ± 3.9 6.8 ± 2.8
CD19 + CD23+ (%) 6.6 ± 3.6 6.9 ± 2.9 7.8 ± 2.5
CD4 + CD25+ (%) 7.4 ± 3.5 6.0 ± 3.7 7.0 ± 2.4
Chest X-rays (LRTI) * n = 171 n = 66 n = 13
Lobar consolidation (%) 23 (13.5) 7 (10.6) 2 (15.4)
Infiltration/opacities (%) 105 (61.4) 41 (62.1) 8 (61.5)
Hyper aeration (%) 16 (9.4) 10 (15.2) 2 (15.4)
Interstitial lesions (%) 59 (34.5) 25 (37.9) 4 (30.8)
Pleural reaction (%) 4 (2.3) 0 (0) 1 (7.7)
Tidal lung function (LRTI) n = 82 n = 54 n = 9
Normal (0) 13 (15.9) 9 (16.7) 1 (11.1)
Mild (1–3) 22 (26.8) 6 (11.1) 1 (11.1)
Moderate (4–5) 23 (28.0) 18 (33.3) 1 (11.1)
Severe (6–7) 20 (24.3) 17 (31.5) 4 (44.4)
Extremely severe (8–9) 4 (4.9) 4 (7.4) 2 (22.2)
*Chest X-rays and tidal lung function were only performed on children with LRTI. CD cluster of differentiation, LRTI lower respiratory tract infection.
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years in Japan, while another study in Germany did not
show any correlation [19]. However, we presume that
climatic conditions in our area are similar to Japan,
and different from the northwestern region of Germany
where the range of temperatures across the seasons is not
as great.
Regarding C. pneumoniae infections, the 6.0% rate in
children with ARTIs found in the present study is simi-
lar to the 6.7% (4/112) found in a study performed by
Kurz et al. [20] in Vienna, Austria, and lower than the
9.3% reported by Schmidt et al. [21] for Greifswald,
Germany. No seasonality or correlation with climatic
conditions was found in our study. Studies conducted in
various countries have shown that M. pneumoniae and
C. pneumoniae infections are most common in school-
aged children, followed by children from 1 to 5 years
old, but rare in infants [16,21-24]. In contrast, we found
that M. pneumoniae (10.8%) and C. pneumoniae (5.9%)
infections are also common in infants. The high population
density in China, which increases exposure and the chance
of infection, may be an important influence in acquiring
these infections.The use of PCR in the present study provided rapid
and specific diagnosis of M. pneumoniae and C.
pneumoniae infections. A recent retrospective study
comparing the diagnostic value of PCR to the indirect
particle agglutination antibody test for M. pneumoniae
infection in children from NPA samples found that PCR
provided a more rapid diagnosis, particularly in young
children (P = 0.003), immunocompromised patients
(P = 0.019), and during the early stage of the disease
[25]. When PCR is combined with serological tests
the yield increases further [26].
In the present study, the clinical manifestations and
laboratory findings did not differ between M. pneumoniae
and C. pneumoniae. Cough and fever were the most
common symptoms. Fever was noticed more frequently in
children with co-infection, although co-infection did not
increase the severity of clinical manifestations. The rate of
wheezing in M. pneumoniae or C. pneumoniae infections
was higher than that reported by Esposito et al. [27], and
the rates of dyspnea and tachypnea were lower. The rea-
son for this may be that the present study included upper
respiratory infection, bronchitis, and asthma exacerbation
within the definition of ARTIs.
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pneumoniae infections with asthma exacerbation in this
study indicates a possible role of infection by these atypical
pathogens in asthma exacerbation. Recently, it was reported
that in asthma M. pneumoniae and C. pneumoniae
appeared to be involved more with asthma persistence than
exacerbation [28].
In previous studies, no significant difference was found
between M. pneumoniae and C. pneumoniae infections
with regard to white blood cell count, C-reactive protein,
percentage of neutrophils, platelets, or radiographic data
[16,27,29]. To the best of our knowledge, this study is
the first to analyze the humoral and cell immunity status
and tidal lung function of children with M. pneumoniae
and C. pneumoniae infections. Although no significant
difference in immunity status existed between the
patients infected with the two pathogens, some studies
showed a depressed humoral and cellular immunity in chil-
dren with M. pneumoniae infection compared to healthy
children [30,31]. Because of the difficulty in distinguishing
M. pneumoniae infection from C. pneumoniae on the basis
of clinical manifestations or laboratory findings, PCR tests
are very useful [32].
The limitations of our study include a probable bias,
as the study was conducted only in hospitalized children
and not outpatients. In addition, a study period of only
one year is relatively short to assess the epidemiology of
M. pneumoniae and C. pneumoniae infection.
Conclusion
M. pneumoniae infections in children demonstrated a def-
inite seasonality, a strong correlation with the temperature,
and a weak correlation with wind velocity. Consistent with
former studies, ours indicates that M. pneumoniae and C.
pneumoniae are important in children with ARTIs who are
younger than 5 years old, and especially in infants. Clinical
manifestations and laboratory findings were informative,
but real-time PCR and nested-PCR provide adequate
rapid and specific diagnosis of M. pneumoniae and C.
pneumoniae infections.
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